
Destiny Pharma has announced the appointment of Chris Tovey, who will be replacing Dr Debra Barker as chief executive officer; …

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

